Literature DB >> 8230446

Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.

M E Lenburg1, N R Landau.   

Abstract

Two functions have been attributed to the product of the human immunodeficiency virus type 1 vpu open reading frame: it increases virion release from infected cells and induces rapid degradation of CD4 shortly after its synthesis. In the absence of Vpu, newly synthesized gp160 and CD4 associate in the endoplasmic reticulum (ER), forming a complex whose further maturation is blocked and which is eventually degraded. In studies using NL4-3-based expression vectors, it has been previously shown that Vpu induces the release of gp160 from the complex that it forms with CD4 in the ER. This release, which appears to be due to the rapid degradation of CD4 induced by Vpu, allows gp160 to transit to the Golgi, where it matures further. We investigated which regions of CD4 are important for its susceptibility to Vpu-induced degradation by transfecting HeLa cells with isogenic vpu-positive and vpu-negative proviruses and vectors expressing various truncated or mutated CD4 molecules. The results suggested that the cytoplasmic domain of CD4 contains a determinant lying within amino acids 418 to 425 that is critical for susceptibility to Vpu-induced degradation. Neither the phosphorylation sites in the cytoplasmic domain nor the Lck interaction region was required for the effect. Vpu-induced degradation was specific for CD4, since CD8, even when retained in the ER, was not degraded. In addition, under conditions of high-level Vpu expression, CD4 degradation could be observed in the absence of gp160 or other means of retaining CD4 in the ER.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230446      PMCID: PMC238186     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes.

Authors:  Y Misumi; Y Misumi; K Miki; A Takatsuki; G Tamura; Y Ikehara
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

2.  A novel gene of HIV-1, vpu, and its 16-kilodalton product.

Authors:  K Strebel; T Klimkait; M A Martin
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 4.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

5.  The effect of vpu on HIV-1-induced syncytia formation.

Authors:  X J Yao; S Garzon; F Boisvert; W A Haseltine; E A Cohen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-02

6.  Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene.

Authors:  L L Stuve; S Brown-Shimer; C Pachl; R Najarian; D Dina; R L Burke
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

7.  Identification of a protein encoded by the vpu gene of HIV-1.

Authors:  E A Cohen; E F Terwilliger; J G Sodroski; W A Haseltine
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

8.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

Authors:  N R Landau; M Warton; D R Littman
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

10.  Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

Authors:  P Bedinger; A Moriarty; R C von Borstel; N J Donovan; K S Steimer; D R Littman
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

View more
  43 in total

Review 1.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

Review 2.  The Vpu protein: new concepts in virus release and CD4 down-modulation.

Authors:  Autumn Ruiz; John C Guatelli; Edward B Stephens
Journal:  Curr HIV Res       Date:  2010-04       Impact factor: 1.581

Review 3.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

4.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 5.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

6.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.

Authors:  C R Casella; E L Rapaport; T H Finkel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

10.  Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.

Authors:  Ilias Christodoulopoulos; Magali E Droniou-Bonzom; Jill E Oldenburg; Paula M Cannon
Journal:  Retrovirology       Date:  2010-01-26       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.